The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary Disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution
Pope III, C. A. (2002) · JAMA · doi:10.1001/jama.287.9.1132 · Cited by 8,447
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Fine Particulate Air Pollution and Mortality in 20 U.S. Cities, 1987–1994
Samet, J. M., Dominici, F., Curriero, F. C., Coursac, I., & Zeger, S. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012143432401 · Cited by 2,237
Fine Particulate Air Pollution and Mortality in 20 U.S. Cities
(2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441614 · Cited by 1,894
Increased Particulate Air Pollution and the Triggering of Myocardial Infarction
Peters, A., Dockery, D. W., Muller, J. E., & Mittleman, M. A. (2001) · Circulation · doi:10.1161/01.cir.103.23.2810 · Cited by 1,471
Sin, D. D., & Man, S. F. P. (2003) · Circulation · doi:10.1161/01.cir.0000056767.69054.b3 · Cited by 1,082
Hole, D. J., Watt, G. C. M., Davey-Smith, G., Hart, C. L., Gillis, C. R., & Hawthorne, V. M. (1996) · BMJ · doi:10.1136/bmj.313.7059.711 · Cited by 911
Particulate air pollution induces progression of atherosclerosis
Suwa, T., Hogg, J. C., Quinlan, K. B., Ohgami, A., Vincent, R., & van Eeden, S. F. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01715-1 · Cited by 611
Pulmonary Function Is a Long-term Predictor of Mortality in the General Population
Schu¨nemann, H. J., Dorn, J., Grant, B. J. B., Winkelstein, W., & Trevisan, M. (2000) · Chest · doi:10.1378/chest.118.3.656 · Cited by 590
Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment
Benowitz, N. L. (2003) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(03)00087-2 · Cited by 424
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease
Sin, D. D. (2005) · Thorax · doi:10.1136/thx.2005.045385 · Cited by 307
Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury
Jacobson, J. R., Barnard, J. W., Grigoryev, D. N., Ma, S.-F., Tuder, R. M., & Garcia, J. G. N. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00354.2004 · Cited by 270
Lévesque, L. E., Brophy, J. M., & Zhang, B. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00113 · Cited by 249
Self-citationAngiotensin II Is Mitogenic for Human Lung Fibroblasts via Activation of the Type 1 Receptor
MARSHALL, R. P., McANULTY, R. J., & LAURENT, G. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.6.9907004 · Cited by 207
Lung Function and Risk of Myocardial Infarction and Sudden Cardiac Death
Friedman, G. D., Klatsky, A. L., & Siegelaub, A. B. (1976) · New England Journal of Medicine · doi:10.1056/nejm197605132942001 · Cited by 206
Molteni, J. E. M. (2000) · International Journal of Radiation Biology · doi:10.1080/095530000138538 · Cited by 200
Prospects for new drugs for chronic obstructive pulmonary disease
Barnes, P. J., & Hansel, T. T. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17025-6 · Cited by 189
The nested case-control study in cardiology
Essebag, V., Genest, J., Suissa, S., & Pilote, L. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00512-x · Cited by 173
Attenuation of chronic hypoxic pulmonary hypertension by simvastatin
Girgis, R. E., Li, D., Zhan, X., Garcia, J. G. N., Tuder, R. M., Hassoun, P. M., & Johns, R. A. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01097.2002 · Cited by 158
Kothe, H., Dalhoff, K., Rupp, J., Müller, A., Kreuzer, J., Maass, M., & Katus, H. A. (2000) · Circulation · doi:10.1161/01.cir.101.15.1760 · Cited by 151
Association Between Pulmonary Fibrosis and Coronary Artery Disease
Kizer, J. R., Zisman, D. A., Blumenthal, N. P., Kotloff, R. M., Kimmel, S. E., Strieter, R. M., Arcasoy, S. M., Ferrari, V. A., & Hansen-Flaschen, J. H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.5.551 · Cited by 150
Otsuka, M., Takahashi, H., Shiratori, M., Chiba, H., & Abe, S. (2003) · Thorax · doi:10.1136/thx.2003.000893 · Cited by 118
Angiotensin receptor subtype AT1 mediates alveolar epithelial cell apoptosis in response to ANG II
Papp, M., Li, X., Zhuang, J., Wang, R., & Uhal, B. D. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00103.2001 · Cited by 115
Treatment of stable chronic obstructive pulmonary disease
Rennard, S. I. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16941-9 · Cited by 106
Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo
Li, X., Zhang, H., Soledad‐Conrad, V., Zhuang, J., & Uhal, B. D. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00273.2002 · Cited by 100
Radiation pneumotoxicity in rats: Modification by inhibitors of angiotensin converting enzyme
Ward, W. F., Molteni, A., Ts'ao, C., Kim, Y. T., & Hinz, J. M. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90890-t · Cited by 85
Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction
Suissa, S. (2003) · Thorax · doi:10.1136/thorax.58.1.43 · Cited by 80
Inhibition of Amiodarone‐Induced Lung Fibrosis but not Alveolitis by Angiotensin System Antagonists
Uhal, B. D., Wang, R., Laukka, J. J., Zhuang, J., Soledad‐Conrad, V., & Filippatos, G. S. (2003) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2003.920204.x · Cited by 76
Cigarette smoking and cardiovascular disease
Jeremy, J. Y., Mikhailidis, D. P., & Pittilo, R. M. (1995) · Journal of the Royal Society of Health · doi:10.1177/146642409511500505 · Cited by 37
Captopril inhibits the pulmonary toxicity of paraquat in rats
Candan, F., & Alagözlü, H. (2001) · Human & Experimental Toxicology · doi:10.1191/096032701718890540 · Cited by 32
Angiotensin II type 1 receptor blocker inhibits pulmonary injury.
Mancini, G. B. J., & Khalil, N. (2005) · PubMed · Cited by 32
Self-citationThe use of cholesterol-lowering medications after coronary revascularization.
Brophy, J. M., Bourgault, C., & Brassard, P. (2003) · Europe PMC (PubMed Central) · Cited by 15
Self-citation
Cited by
Spruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
Mannino, D. M., Thorn, D., Swensen, A., & Holguin, F. (2008) · European Respiratory Journal · doi:10.1183/09031936.00012408 · Cited by 1,184
Chronic obstructive pulmonary disease
Decramer, M., Janssens, W., & Miravitlles, M. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60968-9 · Cited by 972
From COPD to chronic systemic inflammatory syndrome?
Fabbri, L. M., & Rabe, K. F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61383-x · Cited by 635
Metadata
- Authors
- Mancini, G. B. J., Etminan, M., Zhang, B., Levesque, L. E., FitzGerald, J. M., & Brophy, J. M.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 47
- Issue
- 12
- Pages
- 2554-2560
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2077456873
- Cited by
- 402
- References
- 32
- FWCI
- 26.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.